The wire › SEC Form 8-K
Omega Therapeutics, Inc. OMGA
Filed with the SEC on Feb 3, 2025. Reported event date Jan 29, 2025.
- Business address
- Cambridge, MA
- State
- Massachusetts
- Incorporated in
- Delaware
- Industry
- Manufacturing (SIC 2836)
- SEC CIK
- 1850838
- Accession number
- 0001193125-25-019359
Items reported in this filing
- Item 1.01 Entry into a Material Definitive Agreement
- Item 1.02 Termination of a Material Definitive Agreement
- Item 2.03 Creation of a Direct Financial Obligation
- Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
An exchange told the company it does not meet a continued-listing rule, or the company is delisting or moving its listing: Form 8-K Item 3.01. Many of these are compliance notices with time to fix, not closures.
- Item 5.02 Departure or Appointment of Directors or Officers; Compensatory Arrangements
- Item 8.01 Other Events
Other entries on the wire for this company
Wire Pass $1.95/month or $19.50/year lets you watch up to 100 companies like this one. Free during preview See pricing